// App-Quantinova.ai

OR1‐002 : Real world experience with brentuximab vedotin in relapsed/refractory CD30 positive lymphoma: outcomes in 33 patients after prolonged follow‐up at a single UK Centre

Researchers

Presenter

  • K Piddock

Principal Investigators

  • S Atabani

  • A Gibb

  • A Bloor

  • J Murray

  • S Kulkarni

  • T Illidge

  • K Linton

  • J Radford

Medical Centers

  • The Christie NHS Foundation Trust, UK

  • Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 30

Drug/Treatment

  • Adcetris

  • Allopurinol

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved